Establishment Labs Holdings Inc (FRA:3E0)
€ 43.2 0 (0%) Market Cap: 1.20 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 41.09 GF Score: 78/100

Establishment Labs Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 12, 2021 / 03:00PM GMT
Release Date Price: €68
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Okay. I hear the chime. So that means it's time for the medtech portion of the conference. Welcome to day 2.5 of our in-person conference here in Laguna, and I hope you're having a good time. I know I am.

So this morning, in our first session, we have management from Establishment Labs. To my left here is Juan Jose Chacon, who's the President, CEO and Founder of the company; and then directly to his left is Raj Denhoy, who's joined as Head of Strategy and IR, who many of you, I'm sure, know.

So this will be a fireside chat. I have a lot of questions to ask. (Operator Instructions)

So guys, thanks a lot for joining us and looking forward to the conversation.

Juan Jose Chacon Quiros
Establishment Labs Holdings Inc. - Founder, CEO & Executive Director

Good morning, and thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot